MiniMed Group, Inc.
MMEDUnited States
5 filed reports · 302 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
5 reports · Jan 2026 to Jul 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 2 guidance figures, 37 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 2 | 4 | Apr 2026 to Jul 2026 |
| Quarterly · 10-QSEC EDGAR | 2 | 462 | Jan 2026 to Jul 2026 |
| Annual · 10-KSEC EDGAR | 1 | 816 | Apr 2026 |
Financial data
302 concepts · 1,282 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial296 concepts · 1,212 facts · Apr 2024 to Jul 2026
- Stockholders equity (US GAAP)13 · Apr 2024 to Jul 2026
- Profit loss12 · Apr 2024 to Jul 2026
- Standard product warranty accrual12 · Apr 2024 to Jul 2026
- Other comprehensive income loss net of tax portion attributable to parent11 · Apr 2024 to Apr 2026
- Cash cash equivalents restricted cash and restricted cash equivalents10 · Apr 2024 to Jul 2026
- Allocated share based compensation expense9 · Apr 2024 to Jul 2026
- Amortization of intangible assets9 · Apr 2024 to Jul 2026
- Comprehensive income net of tax9 · Apr 2024 to Jul 2026
- Cost of goods and services sold (US GAAP)9 · Apr 2024 to Jul 2026
- Gain loss related to litigation settlement9 · Apr 2024 to Jul 2026
- Goodwill impairment loss9 · Apr 2024 to Jul 2026
- Gross profit (US GAAP)9 · Apr 2024 to Jul 2026
- Impairment of intangible assets finitelived9 · Apr 2024 to Jul 2026
- Income tax expense benefit9 · Apr 2024 to Jul 2026
- Net income loss9 · Apr 2024 to Jul 2026
- Net income loss attributable to noncontrolling interest9 · Apr 2024 to Jul 2026
- Operating income loss9 · Apr 2024 to Jul 2026
- Other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax9 · Apr 2024 to Jul 2026
- Other nonoperating income expense9 · Apr 2024 to Jul 2026
- Other operating income expense net9 · Apr 2024 to Jul 2026
- Research and development expense excluding acquired in process cost9 · Apr 2024 to Jul 2026
- Revenue9 · Apr 2024 to Jul 2026
- Selling general and administrative expense9 · Apr 2024 to Jul 2026
- Standard product warranty accrual payments9 · Apr 2024 to Jul 2026
Product2 concepts · 39 facts · Apr 2024 to Jul 2026
- Revenue36 · Apr 2024 to Jul 2026
- Selling general and administrative expense3 · Apr 2024 to Apr 2026
Geography3 concepts · 27 facts · Apr 2024 to Jul 2026
- Revenue18 · Apr 2024 to Jul 2026
- Italy7 · Jul 2024 to Jul 2026
- Property, Plant & Equipment, Net2 · Apr 2025 to Apr 2026
Guidance1 concepts · 4 facts · Jun 2026 to Sep 2026
- Revenue Growth Guidance4 · Jun 2026 to Sep 2026
Segments
66 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service5 members · 39 facts
- Consumables9 · Apr 2024 to Jul 2026
- Continuous Glucose Monitoring Systems CGM9 · Apr 2024 to Jul 2026
- Product And Service Other9 · Apr 2024 to Jul 2026
- Pumps9 · Apr 2024 to Jul 2026
- Shipping And Handling3 · Apr 2024 to Apr 2026
Statement geographical4 members · 27 facts
- Non Us9 · Apr 2024 to Jul 2026
- US9 · Apr 2024 to Jul 2026
- IT7 · Jul 2024 to Jul 2026
- Us2 · Apr 2025 to Apr 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary12 claims from 1 reports · Jun 2026
- Management discussion (MD&A) commentary25 claims from 1 reports · Jul 2026
Earnings calls
1 calls · Sep 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2027 Q1Sep 1, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.